COMMUNIQUÉS West-GlobeNewswire

RTG Medical Ranks #70 on Inc. 5000 Regionals List in the Midwest
27/02/2024
FREMONT, Neb., Feb. 26, 2024 (GLOBE NEWSWIRE) -- RTG Medical, a leading healthcare staffing agency, has been recognized as one of the top performers in the Midwest, securing the impressive #70 spot on the prestigious [...]
Ibogaine Treatment May Be More Effective During the Month of March, According to David Dardashti
26/02/2024
Miami, FL - Ibogaine by David Dardashti Suggests Theory Behind the Theory MIAMI, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Mental health advocate David Dardashti has suggested that the month of March may be the most effective [...]
Premier Health Reports 2024 First Quarter Results
26/02/2024
MONTRÉAL, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA ) (the “ Corporation ”), a leading Canadian Healthtech company, announces it has filed its Unaudited Quarterly Consolidated Financial [...]
Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement
26/02/2024
PALO ALTO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid [...]
Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference
26/02/2024
REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) [...]
Teladoc Health to Participate in Upcoming Investor Conference
26/02/2024
PURCHASE, NY, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that Mala Murthy, chief financial officer, will participate in the TD [...]
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
26/02/2024
PDUFA target action date for tovorafenib NDA in relapsed or progressive pLGG remains set for April 30, 2024 Phase 2 FIREFLY-1 tovorafenib registrational data published in Nature Medicine Ended 2023 with $366.3 million [...]
Travere Therapeutics to Present at Upcoming Investor Conferences
26/02/2024
SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will participate in the following upcoming investor conferences in March: Cowen 44 th Annual [...]
Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
26/02/2024
MELBOURNE, Australia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire IsoTherapeutics Group, LLC ( [...]
HWH International Inc. Acquires Café in South Korea, Unveiling Second Hapi Cafe Outlet
26/02/2024
Bethesda, MD, Feb. 26, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (“HWH”) (Nasdaq: HWH) proudly announces the acquisition of a café in Seocho-gu, South Korea, marking the launch of its second Hapi Cafe outlet in [...]
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
26/02/2024
SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results [...]
FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
26/02/2024
• Topline data from two pivotal pamrevlumab pancreatic cancer trials anticipated in 2Q 2024 • Additional data from Phase 1 monotherapy study of FG-3246 in metastatic castration-resistant prostate cancer (mCRPC) expected [...]
Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress
26/02/2024
Revolution Medicines to hold webcast today at 4:30 p.m. Eastern Time REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing [...]
Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche
26/02/2024
REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into an agreement with Roche for an exclusive, global license [...]
Relay Therapeutics to Participate in Three Upcoming Investor Conferences
26/02/2024
CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational [...]
GeneDx to Participate in 44th Annual Cowen Health Care Conference
26/02/2024
STAMFORD, Conn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced that company management will participate in [...]
IO Biotech to Present at 44th Annual Cowen Health Care Conference
26/02/2024
NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win® platform, announced [...]
Lyell Immunopharma Announces Participation in March Investor Conferences
26/02/2024
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with [...]
Clover Health to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
26/02/2024
FRANKLIN, Tenn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report fourth quarter and full year 2023 [...]

Pages